Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Longnecker

Showing results (51-60 of 151) with videos related to

Pageof 16
Sort By:
Virology|February 13, 2013
Drosophila Schneider 2 (S2) cells: a novel tool for studying HSV-induced membrane fusionQing Fan, Kevin P Bohannon, Richard Longnecker
Mbio|December 5, 2025
Species-specific gB ectodomain interactions and cytoplasmic domain stability regulate herpes simplex virus fusionQing Fan, Richard Longnecker, Sarah A Connolly
Biorxiv : the Preprint Server for Biology|February 9, 2026
Glycoprotein C Mutations Regulate the Plaque Size of Fusion-Defective Herpes Simplex VirusQing Fan, Richard Longnecker, Sarah A Connolly
Mbio|January 24, 2013
Modulation of Epstein-Barr virus glycoprotein B (gB) fusion activity by the gB cytoplasmic tail domainNicholas J Garcia, Jia Chen, Richard Longnecker
Journal of the National Cancer Institute|August 21, 2003
Absence of the Epstein-Barr virus genome in breast cancer-derived cell linesPeter Speck, David F Callen, Richard Longnecker
Advances in Virus Research|August 24, 2019
Gammaherpesvirus entry and fusion: A tale how two human pathogenic viruses enter their host cellsBritta S Möhl, Jia Chen, Richard Longnecker
Mbio|May 28, 2020
The Innate Immune Response to Herpes Simplex Virus 1 Infection Is Dampened in the Newborn Brain and Can Be Modulated by Exogenous Interferon Beta To Improve SurvivalDaniel Giraldo, Douglas R Wilcox, Richard Longnecker
Journal of Virology|July 1, 2006
Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitroMichelle Swanson-Mungerson, Rebecca Bultema, Richard Longnecker
The Journal of General Virology|May 21, 2010
Epstein-Barr virus LMP2A imposes sensitivity to apoptosisMichelle Swanson-Mungerson, Rebecca Bultema, Richard Longnecker
Frontiers in Bioscience : a Journal and Virtual Library|January 30, 2002
The LMP2A signalosome--a therapeutic target for Epstein-Barr virus latency and associated diseaseToni Portis, Lori Cooper, Patrick Dennis, et al.
Pageof 16

Showing results (51-60 of 151) with videos related to

Sort By:
Pageof 16
Virology|February 13, 2013
Drosophila Schneider 2 (S2) cells: a novel tool for studying HSV-induced membrane fusionQing Fan, Kevin P Bohannon, Richard Longnecker
Mbio|December 5, 2025
Species-specific gB ectodomain interactions and cytoplasmic domain stability regulate herpes simplex virus fusionQing Fan, Richard Longnecker, Sarah A Connolly
Biorxiv : the Preprint Server for Biology|February 9, 2026
Glycoprotein C Mutations Regulate the Plaque Size of Fusion-Defective Herpes Simplex VirusQing Fan, Richard Longnecker, Sarah A Connolly
Mbio|January 24, 2013
Modulation of Epstein-Barr virus glycoprotein B (gB) fusion activity by the gB cytoplasmic tail domainNicholas J Garcia, Jia Chen, Richard Longnecker
Journal of the National Cancer Institute|August 21, 2003
Absence of the Epstein-Barr virus genome in breast cancer-derived cell linesPeter Speck, David F Callen, Richard Longnecker
Advances in Virus Research|August 24, 2019
Gammaherpesvirus entry and fusion: A tale how two human pathogenic viruses enter their host cellsBritta S Möhl, Jia Chen, Richard Longnecker
Mbio|May 28, 2020
The Innate Immune Response to Herpes Simplex Virus 1 Infection Is Dampened in the Newborn Brain and Can Be Modulated by Exogenous Interferon Beta To Improve SurvivalDaniel Giraldo, Douglas R Wilcox, Richard Longnecker
Journal of Virology|July 1, 2006
Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitroMichelle Swanson-Mungerson, Rebecca Bultema, Richard Longnecker
The Journal of General Virology|May 21, 2010
Epstein-Barr virus LMP2A imposes sensitivity to apoptosisMichelle Swanson-Mungerson, Rebecca Bultema, Richard Longnecker
Frontiers in Bioscience : a Journal and Virtual Library|January 30, 2002
The LMP2A signalosome--a therapeutic target for Epstein-Barr virus latency and associated diseaseToni Portis, Lori Cooper, Patrick Dennis, et al.
Pageof 16